Anabolic and catabolic signaling oppose one another in adipose tissue to maintain cellular and organismal homeostasis, but these pathways are often dysregulated in metabolic disorders. Although it has long been established that stimulation of the β-adrenergic receptor inhibits insulin-stimulated glucose uptake in adipocytes, the mechanism has remained unclear. Here we report that β-adrenergic-mediated inhibition of glucose uptake requires lipolysis. We also show that lipolysis suppresses glucose uptake by inhibiting the mammalian target of rapamycin (mTOR) complexes 1 and 2 through complex dissociation. In addition, we show that products of lipolysis inhibit mTOR through complex dissociation in vitro. These findings reveal a previously unre...
The mammalian target of rapamycin (mTOR) is a conserved serine-threonine kinase that regulates cell ...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays an important role i...
Rapamycin is an immunosuppressive agent used after organ transplantation, but its molecular effects ...
International audienceBrown adipose tissue is the primary site for thermogenesis and can consume, in...
A classic metabolic concept posits that insulin promotes energy storage and adipose expansion, while...
Control of fatty acid storage and release in adipose tissue is fundamental in energy homeostasis and...
The prevalence of obesity has over the last 40 years nearly tripled and obesity is one of the major ...
We have shown previously that insulin attenuates β1-adrenergic receptor (β1-AR)-mediated lipolysis v...
Adrenergic signalling is part of the sympathetic nervous system and is activated upon stimulation by...
Pharmacological agents targeting the mTOR complexes are used clinically as immunosuppressants and an...
SummaryIdentification of key regulators of lipid metabolism and thermogenic functions has important ...
Mammalian target of rapamycin complex 2 (mTORC2) is a protein kinase complex that plays an important...
The effect of acute inhibition of both mTORC1 and mTORC2 on metabolism is unknown. A single injectio...
When energy is needed, white adipose tissue (WAT) provides fatty acids (FAs) for use in peripheral t...
Having healthy adipose tissue is essential for metabolic fitness. This is clear from the obesity epi...
The mammalian target of rapamycin (mTOR) is a conserved serine-threonine kinase that regulates cell ...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays an important role i...
Rapamycin is an immunosuppressive agent used after organ transplantation, but its molecular effects ...
International audienceBrown adipose tissue is the primary site for thermogenesis and can consume, in...
A classic metabolic concept posits that insulin promotes energy storage and adipose expansion, while...
Control of fatty acid storage and release in adipose tissue is fundamental in energy homeostasis and...
The prevalence of obesity has over the last 40 years nearly tripled and obesity is one of the major ...
We have shown previously that insulin attenuates β1-adrenergic receptor (β1-AR)-mediated lipolysis v...
Adrenergic signalling is part of the sympathetic nervous system and is activated upon stimulation by...
Pharmacological agents targeting the mTOR complexes are used clinically as immunosuppressants and an...
SummaryIdentification of key regulators of lipid metabolism and thermogenic functions has important ...
Mammalian target of rapamycin complex 2 (mTORC2) is a protein kinase complex that plays an important...
The effect of acute inhibition of both mTORC1 and mTORC2 on metabolism is unknown. A single injectio...
When energy is needed, white adipose tissue (WAT) provides fatty acids (FAs) for use in peripheral t...
Having healthy adipose tissue is essential for metabolic fitness. This is clear from the obesity epi...
The mammalian target of rapamycin (mTOR) is a conserved serine-threonine kinase that regulates cell ...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that plays an important role i...
Rapamycin is an immunosuppressive agent used after organ transplantation, but its molecular effects ...